Core Scientific, Inc. CORZ Ratios & Valuation
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 16.9%+5.0pp | 11.9%+5.3pp | 6.6%+1.4pp | 5.1%-7.4pp | 12.6%-11.1pp | |
| Operating margin | -144.7%-66.4pp | -78.4%-19.7pp | -58.7%-7.1pp | -51.6%+7.8pp | -59.5%-31.6pp | |
| EBITDA margin | -126.2%-69.4pp | -56.8%-22.3pp | -34.5%-9.6pp | -24.9%+9.3pp | -34.2%-28.5pp | |
| Free cash flow margin | -130%+11.3pp | -141.3%-38.4pp | -102.9%-29.3pp | -73.7%-32.0pp | -41.7%-31.5pp | |
| Efficiency | ||||||
| Asset turnover | 0.2×0.0× | 0.2×0.0× | 0.2×0.0× | 0.3×-0.1× | 0.3×-0.1× | |
| Liquidity | ||||||
| Current ratio | 0.5×-0.6× | 1.1×-0.4× | 1.6×-0.2× | 1.8×-2.5× | 4.3×-2.5× | |
| Quick ratio | 0.5×-0.6× | 1.1×-0.4× | 1.6×-0.2× | 1.8×-2.5× | 4.3×-2.5× | |
| Cash ratio | 0.4×0.0× | 0.4×-0.3× | 0.7×-0.4× | 1×-2.5× | 3.6×-2.6× | |
| Leverage | ||||||
| Debt-to-assets | 0.7×+0.2× | 0.5×0.0× | 0.5×-0.1× | 0.6×-0.1× | 0.7×-0.1× | |
| Per Share | ||||||
| Book value per share | -$4.04-33.6% | -$3.03+14.5% | -$3.54-5.8% | -$3.35-294% | -$0.85+76.9% | |
| Valuation | ||||||
| Market capitalization | $4.72B+4.5% | $4.51B-18.1% | $5.51B+51.6% | $3.64B+70.3% | $2.14B-45.6% | |
| Enterprise value | $5.73B+6.7% | $5.37B-13.8% | $6.22B+47.6% | $4.22B+61.2% | $2.62B-38.8% | |
| Price / sales | 13.3×-0.9× | 14.2×-2.3× | 16.5×+6.1× | 10.4×+5.2× | 5.2×-2.5× | |
| EV / sales | 16.1×-0.7× | 16.8×-1.8× | 18.6×+6.5× | 12.1×+5.7× | 6.4×-2.0× | |
| Free cash flow yield | -9.8%+0.2pp | -10%-3.7pp | -6.2%+0.8pp | -7.1%+1.0pp | -8%-6.7pp |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Core Scientific, Inc.'s profit margins?
- Core Scientific, Inc. (CORZ) runs a 16.9% gross margin and a -144.7% operating margin, with a -238.9% net margin.
- Where do Core Scientific, Inc.'s ratios come from?
- Every ratio is computed from Core Scientific, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
